We've found
184,457
clinical trials
We've found
184,457
clinical trials
Contraception Clinical Trial
Updated: 4/13/2016
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
Status: Enrolling,
Phase
III
Updated: 4/13/2016
Click here to add this to my saved trials

Contraception Clinical Trial
Updated: 4/13/2016
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
Status: Enrolling,
Phase
III
Updated: 4/13/2016
Click here to add this to my saved trials

Parkinson Disease Clinical Trial
Updated: 12/31/1969
An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Parkinson Disease Clinical Trial
Updated: 12/31/1969
An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Parkinson Disease Clinical Trial
Updated: 12/31/1969
An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Irritable Bowel Syndrome Clinical Trial
Updated: 7/6/2016
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 7/6/2016
Click here to add this to my saved trials

Pneumonia, Bacterial Clinical Trial
Updated: 12/7/2015
A Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia
Status: Enrolling,
Phase
I
Updated: 12/7/2015
Click here to add this to my saved trials

Non-Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Non-Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Type 1 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Type 1 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cancer Clinical Trial
Updated: 12/31/1969
GSK3174998 Alone or With Pembrolizumab in Subjects With Advanced Solid Tumors (ENGAGE-1)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Hemophilia Clinical Trial
Updated: 12/31/1969
ATHN 2: Factor Switching Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Acute Antibody-Mediated Rejection (AMR) Clinical Trial
Updated: 12/31/1969
A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Lupus Nephritis Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Lupus Nephritis Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Lupus Nephritis Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Lupus Nephritis Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Lupus Nephritis Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 12/31/1969
Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
Updated: 10/16/2017
Exercise in Genetic Cardiovascular Conditions
Status: Enrolling
Updated: 10/16/2017
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
Updated: 10/16/2017
Exercise in Genetic Cardiovascular Conditions
Status: Enrolling
Updated: 10/16/2017
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Neurology Clinical Trial
Updated: 4/3/2018
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
Status: Enrolling,
Phase
IV
Updated: 4/3/2018
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Neurology Clinical Trial
Updated: 4/3/2018
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
Status: Enrolling,
Phase
IV
Updated: 4/3/2018
Click here to add this to my saved trials

Aortic Aneurysm Abdominal Clinical Trial
Updated: 12/31/1969
Zenith® p-Branch® Endovascular Graft Pivotal Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Aortic Aneurysm Abdominal Clinical Trial
Updated: 12/31/1969
Zenith® p-Branch® Endovascular Graft Pivotal Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Musculoskeletal Clinical Trial
Updated: 12/31/1969
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Musculoskeletal Clinical Trial
Updated: 12/31/1969
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Musculoskeletal Clinical Trial
Updated: 12/31/1969
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Musculoskeletal Clinical Trial
Updated: 12/31/1969
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Musculoskeletal Clinical Trial
Updated: 12/31/1969
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Musculoskeletal Clinical Trial
Updated: 12/31/1969
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Musculoskeletal Clinical Trial
Updated: 12/31/1969
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 5/2/2016
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 5/2/2016
Click here to add this to my saved trials

Pneumococcal Infections Clinical Trial
Updated: 2/4/2016
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling,
Phase
I, II
Updated: 2/4/2016
Click here to add this to my saved trials

Pneumococcal Infections Clinical Trial
Updated: 2/4/2016
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling,
Phase
I, II
Updated: 2/4/2016
Click here to add this to my saved trials

Pneumococcal Infections Clinical Trial
Updated: 2/4/2016
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling,
Phase
I, II
Updated: 2/4/2016
Click here to add this to my saved trials

Pneumococcal Infections Clinical Trial
Updated: 2/4/2016
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling,
Phase
I, II
Updated: 2/4/2016
Click here to add this to my saved trials

Neuroblastoma Clinical Trial
Updated: 2/13/2018
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Status: Enrolling,
Phase
II
Updated: 2/13/2018
Click here to add this to my saved trials

Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

RLS Clinical Trial
Updated: 12/31/1969
An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

RLS Clinical Trial
Updated: 12/31/1969
An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 4/9/2018
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 4/9/2018
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 6/21/2016
Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation
Status: Enrolling,
Phase
I
Updated: 6/21/2016
Click here to add this to my saved trials

Thromboembolism Clinical Trial
Updated: 12/21/2017
Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates
Status: Enrolling,
Phase
I, II
Updated: 12/21/2017
Click here to add this to my saved trials

Thromboembolism Clinical Trial
Updated: 12/21/2017
Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates
Status: Enrolling,
Phase
I, II
Updated: 12/21/2017
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
